ADRB2 and coronary artery disorder: Network analysis using Cytoscape has identified PTGS2, PTGS1, NCOA2, ADRB2, SCN5A, RXRA, NCOA1, ESR1, AR, and DPP4 as key targets for the treatment of CHD with BYXD.